We are live on
!
Find out more
RBC
Romano Brothers & Co Portfolio holdings
AUM
$994M
1-Year Est. Return
41.36%
This Fund
S&P 500
This Quarter
Est. Return
+8.67%
1 Year Est. Return
+41.36%
3 Year Est. Return
+100.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$803M
AUM Growth
+$80.9M
(+11%)
Cap. Flow
+$23.4M
Cap. Flow
% of AUM
2.92%
Top 10 Holdings %
Top 10 Hldgs %
24.94%
Holding
315
New
15
Increased
109
Reduced
88
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.75M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.05M |
| 3 |
Icon
ICLR
|
+$2.01M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$1.19M |
| 5 |
DraftKings
DKNG
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$2.51M |
| 2 |
Generac Holdings
GNRC
|
+$857K |
| 3 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$393K |
| 4 |
Integra LifeSciences
IART
|
+$338K |
| 5 |
Dollar General
DG
|
+$279K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 13.44% |
| 3 | Industrials | 13.27% |
| 4 | Financials | 8.19% |
| 5 | Consumer Discretionary | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Enpro
NPO
$7.04B
| $208K | 0.03% |
1,280
-220
| -15% | -$34.2K |
|
302
GE Aerospace
GE
$391B
| $207K | 0.03% |
+1,098
| New | +$186K |
|
303
GSK
GSK
$103B
| $206K | 0.03% |
+5,032
| New | +$206K |
|
304
Ameren
AEE
$30.3B
| $204K | 0.03% |
+2,331
| New | +$187K |
|
305
FMC
FMC
$1.31B
| $200K | 0.03% |
+3,040
| New | +$186K |
|
|
WBA
306
DELISTED
Walgreens Boots Alliance
WBA
| $188K | 0.02% |
20,975
-4,812
| -19% | -$49.5K |
|
307
BlackRock TCP Capital
TCPC
$295M
| $125K | 0.02% |
15,075
| – | – |
|
|
BMTX
308
DELISTED
BM Technologies, Inc.
BMTX
| $39.1K | ﹤0.01% |
11,500
| – | – |
|
|
TELL
309
DELISTED
Tellurian Inc.
TELL
| $9.68K | ﹤0.01% |
10,000
| – | – |
|
|
LPTV
310
DELISTED
Loop Media, Inc.
LPTV
| $595 | ﹤0.01% |
12,536
| – | – |
|
311
Associated Banc-Corp
ASB
$5.99B
| – | – |
-12,000
| Closed | -$254K |
|
|
312
Dollar General
DG
$28.1B
| – | – |
-2,113
| Closed | -$279K |
|
|
313
Integra LifeSciences
IART
$1.38B
| – | – |
-11,614
| Closed | -$338K |
|
314
Vanguard Morningstar Value ETF
VTV
$191B
| – | – |
-1,594
| Closed | -$256K |
|
|
PETQ
315
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| – | – |
-17,800
| Closed | -$393K |
|
Similar funds
SMM
SWA
CVM
GCM
HT
KIA
N
WD
Romano Brothers & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Romano Brothers & Co held 315 positions worth $803M, up 11% from $722M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Romano Brothers & Co's Q3 2024 filing shows 15 new, 109 increased, 88 reduced and 5 closed positions. Its largest new stake was SLB Ltd: 61,725 shares worth $2.59M. The largest sale was Albemarle, an estimated $2.51M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Romano Brothers & Co's largest Q3 2024 buy was SLB Ltd: 61,725 shares worth $2.59M.
- Romano Brothers & Co added most to Vanguard Dividend Appreciation ETF in Q3 2024, an estimated $2.05M increase.
- Romano Brothers & Co's biggest Q3 2024 reduction was Albemarle, cutting an estimated $2.51M.
- Romano Brothers & Co fully exited PetIQ, Inc. Class A Common Stock in Q3 2024, selling an estimated $393K.
- Romano Brothers & Co's ten largest holdings make up 25% of its $803M portfolio in Q3 2024.
- Romano Brothers & Co opened 15 new positions and closed 5 in Q3 2024.
- Romano Brothers & Co's portfolio value rose 11% quarter-over-quarter to $803M.
Based on Romano Brothers & Co's 13F filing for Q3 2024, filed 22 Oct 2024.